Tag: thrombectomy
Surmodics receives 510(k) clearance for Pounce LP thrombectomy system
Surmodics announced in a press release that it has received US Food and Drug Administration (FDA) 510(k) clearance for its Pounce LP (low...
Mechanical thrombectomy: ClotTriever offers “extended window” for DVT treatment
This advertorial, sponsored by Inari Medical, is only available in selected countries and geographies.
During a recent webinar hosted by Inari Medical, a multidisciplinary group...
First patient enrolled in PROWL registry study using Pounce thrombectomy system
Surmodics has announced enrolment of the first patient in PROWL, the Pounce thrombectomy system retrospective registry. PROWL is an open-label, retrospective, multicentre US registry...
RESCUE trial shows reduction in segmental and main pulmonary artery occlusions
Robert A Lookstein, who is executive vice chair, Diagnostic, Molecular and Interventional Radiology at the Icahn School of Medicine at Mount Sinai Hospital (New...
Vascular News’ top 10 most popular stories of January 2023
January's top 10 highlights an individual patient data meta-analysis on the safety of carotid endarterectomy in the elderly and a new randomised trial on...
Cardiovascular Systems announces US FDA 510(k) submission of Innova Vascular’s thrombectomy...
Cardiovascular Systems (CSI) announced that Innova Vascular (Innova) has submitted a 510(k) premarket notification to the US Food and Drug Administration (FDA) for its...
New mechanical thrombectomy systems unlock possibilities for the treatment of venous...
This advertorial, sponsored by Inari Medical, is only available in selected countries and geographies.
Mechanical thrombectomy with the ClotTriever and FlowTriever systems (Inari Medical) opens...
Penumbra and Asahi Intecc partner to introduce Indigo System to Japan
Penumbra and Asahi Intecc, a Japanese medical device manufacturer, announced that they will collaborate to introduce Penumbra’s Indigo Aspiration System into the Japanese market...
AngioDynamics announces FDA clearance of expanded indications for Auryon atherectomy system
AngioDynamics recently announced that it has received US Food and Drug Administration (FDA) 510(k) clearance of an expanded indication for the Auryon atherectomy system...
Pounce thrombectomy system first-in-human data show 100% technical success in early...
Surmodics has announced that its Pounce thrombectomy system achieved 100% technical success in 20 first-in-human (FIH) procedures. The FIH data were presented by Gary...
Penumbra announces the European launch of the Indigo system with Lightning...
Penumbra has announced that its Indigo aspiration system with Lightning 7 and Lightning 12 have secured CE mark and are now commercially available in...
Truvic announces US FDA 510(k) clearance for Prodigy thrombectomy system
Truvic Medical, a wholly owned subsidiary of Imperative Care, announced in a press release that it has received 510(k) clearance from the US Food...
Cordis makes strategic investment in E2, a developer of next-generation thrombectomy...
Cordis has announced a strategic investment venture that will expand the scope of the global cardiovascular technology company into the venous thromboembolism (VTE) market...
Cardiovascular Systems partners with Innova Vascular to develop full line of...
Cardiovascular Systems Inc (CSI) recently announced it has partnered with Innova Vascular (Innova) to develop a full line of novel thrombectomy devices.
According to a...
Boston Scientific announces agreement to acquire Devoro Medical
Today, Boston Scientific announced an agreement to acquire Devoro Medical, developer of the Wolf thrombectomy platform. The non-console and lytic-free Wolf technology targets and...
Abbott expands peripheral vascular offerings with acquisition of Walk Vascular
Abbott announced today that it has acquired Walk Vascular, a commercial-stage medical device company with a minimally invasive mechanical aspiration thrombectomy system designed to...
Surmodics announces successful first patient use of Pounce thrombectomy system
Surmodics has announced that J. Michael Bacharach, a vascular interventionalist/cardiologist at North Central Heart, a division of Avera Heart Hospital in Sioux Falls, USA,...
Surmodics builds thrombectomy portfolio with acquisition of Vetex Medical
Surmodics recently announced that it has acquired privately-held Vetex Medical Limited. The Galway, Ireland-based medical device developer and manufacturer has focused exclusively on venous...
AngioDynamics receives 510(k) clearance for AlphaVac mechanical thrombectomy system
AngioDynamics recently announced that it has received 510(k) clearance from the US Food and Drug Administration (FDA) for the AlphaVac mechanical thrombectomy system.
According to...
Mermaid Medical Group reports full commercialisation of the D-Clot HD rotational...
Mermaid Medical Group recently announced US commercial availability of the D-Clot HD rotational thrombectomy system. As of 12 January, the company reports 25 successful...
Philips launches QuickClear mechanical thrombectomy system for blood clot removal in...
Royal Philips has announced the launch of the QuickClear mechanical thrombectomy system. The single-use system delivers an all-in-one aspiration pump and catheter to remove...
Veryan Medical to support commercialisation of Jeti thrombectomy system in Germany
Walk Vascular and Veryan Medical have announced that Veryan Medical will support commercialisation of the Jeti peripheral thrombectomy system (Walk Vascular) in Germany.
Walk Vascular’s...
FDA clears Aspire MAX mechanical thrombectomy system
Control Medical Technology has announced that the US Food and Drug Administration (FDA) has cleared its Aspire MAX 7 – 11F mechanical thrombectomy...
LeMaitre Vascular acquires clot management business from Applied Medical
LeMaitre Vascular has acquired the vascular clot management business of Applied Medical Resources Corporation for US$14.2 million, of which US$11 million was paid at...
Philips acquires CardioProlific
Royal Philips has announced the acquisition of CardioProlific Inc, a USA-based, privately-held company that is developing catheter-based thrombectomy approaches to treat peripheral vascular disease. Financial...
